| nbpower | R Documentation |
Estimates the power for negative binomial rate ratio test.
nbpower(
kMax = 1L,
informationRates = NA_real_,
efficacyStopping = NA_integer_,
futilityStopping = NA_integer_,
criticalValues = NA_real_,
alpha = 0.025,
typeAlphaSpending = "sfOF",
parameterAlphaSpending = NA_real_,
userAlphaSpending = NA_real_,
futilityBounds = NA_real_,
typeBetaSpending = "none",
parameterBetaSpending = NA_real_,
rateRatioH0 = 1,
allocationRatioPlanned = 1,
accrualTime = 0L,
accrualIntensity = NA_real_,
piecewiseSurvivalTime = 0L,
stratumFraction = 1L,
kappa1 = NA_real_,
kappa2 = NA_real_,
lambda1 = NA_real_,
lambda2 = NA_real_,
gamma1 = 0L,
gamma2 = 0L,
accrualDuration = NA_real_,
followupTime = NA_real_,
fixedFollowup = 0L,
spendingTime = NA_real_,
studyDuration = NA_real_,
nullVariance = 0L
)
kMax |
The maximum number of stages. |
informationRates |
The information rates.
Defaults to |
efficacyStopping |
Indicators of whether efficacy stopping is allowed at each stage. Defaults to true if left unspecified. |
futilityStopping |
Indicators of whether futility stopping is allowed at each stage. Defaults to true if left unspecified. |
criticalValues |
Upper boundaries on the z-test statistic scale for stopping for efficacy. |
alpha |
The significance level. Defaults to 0.025. |
typeAlphaSpending |
The type of alpha spending. One of the following: "OF" for O'Brien-Fleming boundaries, "P" for Pocock boundaries, "WT" for Wang & Tsiatis boundaries, "sfOF" for O'Brien-Fleming type spending function, "sfP" for Pocock type spending function, "sfKD" for Kim & DeMets spending function, "sfHSD" for Hwang, Shi & DeCani spending function, "user" for user defined spending, and "none" for no early efficacy stopping. Defaults to "sfOF". |
parameterAlphaSpending |
The parameter value for the alpha spending. Corresponds to Delta for "WT", rho for "sfKD", and gamma for "sfHSD". |
userAlphaSpending |
The user defined alpha spending. Cumulative alpha spent up to each stage. |
futilityBounds |
Lower boundaries on the z-test statistic scale
for stopping for futility at stages 1, ..., |
typeBetaSpending |
The type of beta spending. One of the following: "sfOF" for O'Brien-Fleming type spending function, "sfP" for Pocock type spending function, "sfKD" for Kim & DeMets spending function, "sfHSD" for Hwang, Shi & DeCani spending function, and "none" for no early futility stopping. Defaults to "none". |
parameterBetaSpending |
The parameter value for the beta spending. Corresponds to rho for "sfKD", and gamma for "sfHSD". |
rateRatioH0 |
Rate ratio under the null hypothesis. |
allocationRatioPlanned |
Allocation ratio for the active treatment versus control. Defaults to 1 for equal randomization. |
accrualTime |
A vector that specifies the starting time of
piecewise Poisson enrollment time intervals. Must start with 0, e.g.,
|
accrualIntensity |
A vector of accrual intensities. One for each accrual time interval. |
piecewiseSurvivalTime |
A vector that specifies the starting time of
piecewise exponential survival time intervals. Must start with 0, e.g.,
|
stratumFraction |
A vector of stratum fractions that sum to 1. Defaults to 1 for no stratification. |
kappa1 |
The dispersion parameter (reciprocal of the shape parameter of the gamma mixing distribution) for the active treatment group by stratum. |
kappa2 |
The dispersion parameter (reciprocal of the shape parameter of the gamma mixing distribution) for the control group by stratum. |
lambda1 |
The rate parameter of the negative binomial distribution for the active treatment group by stratum. |
lambda2 |
The rate parameter of the negative binomial distribution for the control group by stratum. |
gamma1 |
The hazard rate for exponential dropout, a vector of hazard rates for piecewise exponential dropout applicable for all strata, or a vector of hazard rates for dropout in each analysis time interval by stratum for the active treatment group. |
gamma2 |
The hazard rate for exponential dropout, a vector of hazard rates for piecewise exponential dropout applicable for all strata, or a vector of hazard rates for dropout in each analysis time interval by stratum for the control group. |
accrualDuration |
Duration of the enrollment period. |
followupTime |
Follow-up time for the last enrolled subject. |
fixedFollowup |
Whether a fixed follow-up design is used. Defaults to 0 for variable follow-up. |
spendingTime |
A vector of length |
studyDuration |
Study duration for fixed follow-up design.
Defaults to missing, which is to be replaced with the sum of
|
nullVariance |
Whether to calculate the variance for log rate ratio under the null hypothesis. |
An S3 class nbpower object with 4 components:
overallResults: A data frame containing the following variables:
overallReject: The overall rejection probability.
alpha: The overall significance level.
numberOfEvents: The total number of events.
numberOfDropouts: The total number of dropouts.
numbeOfSubjects: The total number of subjects.
exposure: The total exposure.
studyDuration: The total study duration.
information: The maximum information.
expectedNumberOfEvents: The expected number of events.
expectedNumberOfDropouts: The expected number of dropouts.
expectedNumberOfSubjects: The expected number of subjects.
expectedExposure: The expected exposure.
expectedStudyDuration: The expected study duration.
expectedInformation: The expected information.
accrualDuration: The accrual duration.
followupTime: The follow-up duration.
fixedFollowup: Whether a fixed follow-up design is used.
kMax: The number of stages.
rateRatioH0: The rate ratio under the null hypothesis.
rateRatio: The rate ratio.
byStageResults: A data frame containing the following variables:
informationRates: The information rates.
efficacyBounds: The efficacy boundaries on the Z-scale.
futilityBounds: The futility boundaries on the Z-scale.
rejectPerStage: The probability for efficacy stopping.
futilityPerStage: The probability for futility stopping.
cumulativeRejection: The cumulative probability for efficacy
stopping.
cumulativeFutility: The cumulative probability for futility
stopping.
cumulativeAlphaSpent: The cumulative alpha spent.
numberOfEvents: The number of events.
numberOfDropouts: The number of dropouts.
numberOfSubjects: The number of subjects.
exposure: The exposure.
analysisTime: The average time since trial start.
efficacyRateRatio: The efficacy boundaries on the rate
ratio scale.
futilityRateRatio: The futility boundaries on the rate
ratio scale.
efficacyP: The efficacy boundaries on the p-value scale.
futilityP: The futility boundaries on the p-value scale.
information: The cumulative information.
efficacyStopping: Whether to allow efficacy stopping.
futilityStopping: Whether to allow futility stopping.
settings: A list containing the following input parameters:
typeAlphaSpending, parameterAlphaSpending,
userAlphaSpending, typeBetaSpending,
parameterBetaSpending, allocationRatioPlanned,
accrualTime, accuralIntensity,
piecewiseSurvivalTime, kappa1, kappa2,
lambda1, lambda2, gamma1, gamma2,
spendingTime, and nullVariance.
byTreatmentCounts: A list containing the following counts by
treatment group:
numberOfEvents1: The number of events by stage for
the treatment group.
numberOfDropouts1: The number of dropouts by stage for
the treatment group.
numberOfSubjects1: The number of subjects by stage for
the treatment group.
exposure1: The exposure by stage for the treatment group.
numberOfEvents2: The number of events by stage for
the control group.
numberOfDropouts2: The number of dropouts by stage for
the control group.
numberOfSubjects2: The number of subjects by stage for
the control group.
exposure2: The exposure by stage for the control group.
expectedNumberOfEvents1: The expected number of events for
the treatment group.
expectedNumberOfDropouts1: The expected number of dropouts
for the treatment group.
expectedNumberOfSubjects1: The expected number of subjects
for the treatment group.
expectedExposure1: The expected exposure for the treatment
group.
expectedNumberOfEvents2: The expected number of events for
control group.
expectedNumberOfDropouts2: The expected number of dropouts
for the control group.
expectedNumberOfSubjects2: The expected number of subjects
for the control group.
expectedExposure2: The expected exposure for the control
group.
Kaifeng Lu, kaifenglu@gmail.com
nbstat
# Example 1: Variable follow-up design
nbpower(kMax = 2, informationRates = c(0.5, 1),
alpha = 0.025, typeAlphaSpending = "sfOF",
accrualIntensity = 1956/1.25,
stratumFraction = c(0.2, 0.8),
kappa1 = 5, kappa2 = 5,
lambda1 = c(0.7*0.125, 0.75*0.25),
lambda2 = c(0.125, 0.25),
gamma1 = 0, gamma2 = 0,
accrualDuration = 1.25,
followupTime = 2.75, fixedFollowup = FALSE,
nullVariance = 1)
# Example 2: Fixed follow-up design
nbpower(kMax = 2, informationRates = c(0.5, 1),
alpha = 0.025, typeAlphaSpending = "sfOF",
accrualIntensity = 220/1.5,
kappa1 = 3, kappa2 = 3,
lambda1 = 0.5*8.4, lambda2 = 8.4,
gamma1 = 0, gamma2 = 0,
accrualDuration = 1.5,
followupTime = 0.5, fixedFollowup = TRUE)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.